234 related articles for article (PubMed ID: 27262016)
1. Omission of axillary dissection after a positive sentinel lymph-node: Implications in the multidisciplinary treatment of operable breast cancer.
Ponzone R; Ruatta F; Gatti M; Castellano I; Geuna E; Amato G; Kubatzki F; Sgandurra P; Sapino A; Montemurro F
Cancer Treat Rev; 2016 Jul; 48():1-7. PubMed ID: 27262016
[TBL] [Abstract][Full Text] [Related]
2. [Management of the axilla in breast cancer: evidences and unresolved issues].
Fodor J; Polgár C; Péley G; Németh G
Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099
[TBL] [Abstract][Full Text] [Related]
3. Axillary lymph node treatment in breast cancer: an update.
Williams PA; Suggs J; Mangana SH
J Miss State Med Assoc; 2014 May; 55(5):145-7. PubMed ID: 25112128
[TBL] [Abstract][Full Text] [Related]
4. Axillary surgery in breast cancer: the beginning of the end.
Dumitru D; Khan A; Catanuto G; Rocco N; Nava MB; Benson JR
Minerva Chir; 2018 Jun; 73(3):314-321. PubMed ID: 29589679
[TBL] [Abstract][Full Text] [Related]
5. Completion axillary lymph node dissection not required for regional control in patients with breast cancer who have micrometastases in a sentinel node.
Yegiyants S; Romero LM; Haigh PI; DiFronzo LA
Arch Surg; 2010 Jun; 145(6):564-9. PubMed ID: 20566977
[TBL] [Abstract][Full Text] [Related]
6. Axillary node interventions in breast cancer: a systematic review.
Rao R; Euhus D; Mayo HG; Balch C
JAMA; 2013 Oct; 310(13):1385-94. PubMed ID: 24084924
[TBL] [Abstract][Full Text] [Related]
7. Omission of sentinel node biopsy for breast cancer: Historical context and future perspectives on a modern controversy.
Jatoi I; Kunkler IH
Cancer; 2021 Dec; 127(23):4376-4383. PubMed ID: 34614216
[TBL] [Abstract][Full Text] [Related]
8. Management of axillary disease.
Caudle AS; Cupp JA; Kuerer HM
Surg Oncol Clin N Am; 2014 Jul; 23(3):473-86. PubMed ID: 24882346
[TBL] [Abstract][Full Text] [Related]
9. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
10. [Impact of omission of axillary dissection on adjuvant therapy in patients with metastatic sentinel lymph nodes according to the ACOSOG Z0011 criteria].
Roosen A; Lousquy R; Bricou A; Delpech Y; Selz J; Le Maignan C; Bousquet G; Winterman S; Zelek L; Barranger E
Gynecol Obstet Fertil; 2014 Jun; 42(6):409-14. PubMed ID: 24861437
[TBL] [Abstract][Full Text] [Related]
11. [Sentinel node biopsy and axillary clearence in early breast cancer--An algorithm with explanations and queries].
Cserni G
Magy Seb; 2016 Mar; 69(1):4-13. PubMed ID: 26901689
[TBL] [Abstract][Full Text] [Related]
12. Can radiotherapy replace axillary dissection for patients with positive sentinel nodes?
Recht A
Breast Dis; 2010; 31(2):91-7. PubMed ID: 21368371
[TBL] [Abstract][Full Text] [Related]
13. Long-term prognoses and outcomes of axillary lymph node recurrence in 2,578 sentinel lymph node-negative patients for whom axillary lymph node dissection was omitted: results from one Japanese hospital.
Ogiya A; Kimura K; Nakashima E; Sakai T; Miyagi Y; Iijima K; Morizono H; Makita M; Horii R; Akiyama F; Iwase T
Breast Cancer; 2016 Mar; 23(2):318-22. PubMed ID: 25376341
[TBL] [Abstract][Full Text] [Related]
14. Update on the NSABP and ACOSOG breast cancer sentinel node trials.
White RL; Wilke LG
Am Surg; 2004 May; 70(5):420-4. PubMed ID: 15156950
[TBL] [Abstract][Full Text] [Related]
15. De-escalation of axillary surgery in early breast cancer.
Jatoi I; Benson JR; Toi M
Lancet Oncol; 2016 Oct; 17(10):e430-e441. PubMed ID: 27733269
[TBL] [Abstract][Full Text] [Related]
16. Sentinel Lymph Nodes for Breast Carcinoma: A Paradigm Shift.
Maguire A; Brogi E
Arch Pathol Lab Med; 2016 Aug; 140(8):791-8. PubMed ID: 27472237
[TBL] [Abstract][Full Text] [Related]
17. Management strategy of early-stage breast cancer patients with a positive sentinel lymph node: With or without axillary lymph node dissection.
Chen JJ; Wu J
Crit Rev Oncol Hematol; 2011 Sep; 79(3):293-301. PubMed ID: 20663684
[TBL] [Abstract][Full Text] [Related]
18. [Breast cancer and axillary area: state of the art and perspectives].
Houvenaeghel G; Cohen M; Chereau Ewald E; Bannier M; Buttarelli M; Jauffret C; Lambaudie E
Bull Cancer; 2013 Dec; 100(12):1311-8. PubMed ID: 24316763
[TBL] [Abstract][Full Text] [Related]
19. [Sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer].
Mátrai Z; Tóth L; Polgár C; Láng I; Gõdény M; Sinkovics I; Horváth Z; Bidlek M; Udvarhelyi N; Bartal A; Sávolt A; Ujhelyi M; Kásler M
Magy Onkol; 2011 Jun; 55(2):73-84. PubMed ID: 21655472
[TBL] [Abstract][Full Text] [Related]
20. Omission of axillary dissection after a positive sentinel node dissection may influence adjuvant chemotherapy indications in operable breast cancer patients.
Montemurro F; Maggiorotto F; Valabrega G; Kubatzki F; Rossi V; Magistris A; Marocco F; Gatti M; Sarotto I; Aglietta M; Ponzone R
Ann Surg Oncol; 2012 Nov; 19(12):3755-61. PubMed ID: 22805871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]